Abstract
Expression of epidermal growth factor receptor (EGFR) may be of prognostic value in renal cell cancer (RCC). Gene amplification of EGFR was investigated in a cohort of 315 patients with advanced RCC from a previously reported randomised study. Using fluorescent in situ hybridisation, only 2 patients (0.6%) had gene amplification; therefore gene amplification is of no prognostic value in RCC. © 2010 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 859-862 |
Number of pages | 3 |
Journal | European Journal of Cancer |
Volume | 46 |
Issue number | 5 |
DOIs | |
Publication status | Published - Mar 2010 |
Keywords
- Epidermal growth factor receptor
- Fluorescent in situ hybridisation
- Renal cell carcinoma